These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
234 related items for PubMed ID: 20206795
1. Influence of Ginkgo biloba extract on the pharmacodynamic effects and pharmacokinetic properties of ticlopidine: an open-label, randomized, two-period, two-treatment, two-sequence, single-dose crossover study in healthy Korean male volunteers. Kim BH, Kim KP, Lim KS, Kim JR, Yoon SH, Cho JY, Lee YO, Lee KH, Jang IJ, Shin SG, Yu KS. Clin Ther; 2010 Feb; 32(2):380-90. PubMed ID: 20206795 [Abstract] [Full Text] [Related]
2. Comparison of the pharmacokinetics of ticlopidine between administration of a combined fixed-dose tablet formulation of ticlopidine 250 mg/ginkgo extract 80 mg, and concomitant administration of ticlopidine 250-mg and ginkgo extract 80-mg tablets: an open-label, two-treatment, single-dose, randomized-sequence crossover study in healthy Korean male volunteers. Kim TE, Kim BH, Kim J, Kim KP, Yi S, Shin HS, Lee YO, Lee KH, Shin SG, Jang IJ, Yu KS. Clin Ther; 2009 Oct; 31(10):2249-57. PubMed ID: 19922896 [Abstract] [Full Text] [Related]
3. Bioequivalence and tolerability of two clopidogrel salt preparations, besylate and bisulfate: a randomized, open-label, crossover study in healthy Korean male subjects. Kim SD, Kang W, Lee HW, Park DJ, Ahn JH, Kim MJ, Kim EY, Kim SW, Nam HS, Na HJ, Yoon YR. Clin Ther; 2009 Apr; 31(4):793-803. PubMed ID: 19446152 [Abstract] [Full Text] [Related]
4. Pharmacodynamics and pharmacokinetics of single doses of prasugrel 30 mg and clopidogrel 300 mg in healthy Chinese and white volunteers: an open-label trial. Small DS, Payne CD, Kothare P, Yuen E, Natanegara F, Teng Loh M, Jakubowski JA, Richard Lachno D, Li YG, Winters KJ, Farid NA, Ni L, Salazar DE, Tomlin M, Kelly R. Clin Ther; 2010 Feb; 32(2):365-79. PubMed ID: 20206794 [Abstract] [Full Text] [Related]
5. Bioequivalence of two tablet formulations of clopidogrel in healthy Argentinian volunteers: a single-dose, randomized-sequence, open-label crossover study. Di Girolamo G, Czerniuk P, Bertuola R, Keller GA. Clin Ther; 2010 Jan; 32(1):161-70. PubMed ID: 20171421 [Abstract] [Full Text] [Related]
7. The effects of ergoloid mesylates and ginkgo biloba on the pharmacokinetics of ticlopidine. Lu WJ, Huang JD, Lai ML. J Clin Pharmacol; 2006 Jun; 46(6):628-34. PubMed ID: 16707409 [Abstract] [Full Text] [Related]
8. Interaction between ticlopidine or warfarin or cardioaspirin with a highly standardized deterpened Ginkgo biloba extract (VR456) in rat and human. Di Pierro F, Rinaldi F, Lucarelli M, Rossoni G. Acta Biomed; 2010 Dec; 81(3):196-203. PubMed ID: 22530457 [Abstract] [Full Text] [Related]
10. Effect of ginkgo biloba on the pharmacokinetics of raltegravir in healthy volunteers. Blonk M, Colbers A, Poirters A, Schouwenberg B, Burger D. Antimicrob Agents Chemother; 2012 Oct; 56(10):5070-5. PubMed ID: 22802250 [Abstract] [Full Text] [Related]
11. Pharmacodynamic (hemodynamic) and pharmacokinetic comparisons of S-amlodipine gentisate and racemate amlodipine besylate in healthy Korean male volunteers: two double-blind, randomized, two-period, two-treatment, two-sequence, double-dummy, single-dose crossover studies. Kim BH, Kim JR, Kim MG, Kim KP, Lee BY, Jang IJ, Shin SG, Yu KS. Clin Ther; 2010 Jan; 32(1):193-205. PubMed ID: 20171424 [Abstract] [Full Text] [Related]
12. Potential interactions between cilostazol and probucol: a two-part, single-dose, open-label study in healthy Korean male volunteers. Kim KP, Kim BH, Lim KS, Kim TE, Shin SG, Jang IJ, Yu KS. Clin Ther; 2009 Oct; 31(10):2098-106. PubMed ID: 19922880 [Abstract] [Full Text] [Related]
13. Antiplatelet and antithrombotic effects of a combination of ticlopidine and ginkgo biloba ext (EGb 761). Kim YS, Pyo MK, Park KM, Park PH, Hahn BS, Wu SJ, Yun-Choi HS. Thromb Res; 1998 Jul 01; 91(1):33-8. PubMed ID: 9700851 [Abstract] [Full Text] [Related]
15. The effect of Ginkgo biloba extracts on the pharmacokinetics and pharmacodynamics of cilostazol and its active metabolites in healthy Korean subjects. Kim HS, Kim GY, Yeo CW, Oh M, Ghim JL, Shon JH, Kim EY, Kim DH, Shin JG. Br J Clin Pharmacol; 2014 May 01; 77(5):821-30. PubMed ID: 24001154 [Abstract] [Full Text] [Related]
16. Comparative pharmacodynamic effects of two clopidogrel formulations under steady-state conditions in healthy Thai volunteers . Nakkam N, Tiamkao S, Kanjanawart S, Phunikhom K, Tiamkao S, Vannaprasaht S, Tassaneeyakul W, Tassaneeyakul W. Int J Clin Pharmacol Ther; 2017 Feb 01; 55(2):177-185. PubMed ID: 27936524 [Abstract] [Full Text] [Related]
17. Pharmacokinetic comparison of orally disintegrating and conventional donepezil formulations in healthy Korean male subjects: a single-dose, randomized, open-label, 2-sequence, 2-period crossover study. Kim KA, Lim JL, Kim C, Park JY. Clin Ther; 2011 Jul 01; 33(7):965-72. PubMed ID: 21723605 [Abstract] [Full Text] [Related]
18. Does Ginkgo biloba special extract EGb 761 provide additional effects on coagulation and bleeding when added to acetylsalicylic acid 500 mg daily? Wolf HR. Drugs R D; 2006 Jul 01; 7(3):163-72. PubMed ID: 16752942 [Abstract] [Full Text] [Related]
19. Influence of a 7-day treatment with Ginkgo biloba special extract EGb 761 on bleeding time and coagulation: a randomized, placebo-controlled, double-blind study in healthy volunteers. Köhler S, Funk P, Kieser M. Blood Coagul Fibrinolysis; 2004 Jun 01; 15(4):303-9. PubMed ID: 15166915 [Abstract] [Full Text] [Related]
20. Comparative pharmacokinetics/pharmacodynamics of clopidogrel besylate and clopidogrel bisulfate in healthy Korean subjects. Kim BH, Kim JR, Lim KS, Shin HS, Yoon SH, Cho JY, Jang IJ, Shin SG, Yu KS. Clin Drug Investig; 2012 Dec 01; 32(12):817-26. PubMed ID: 23026843 [Abstract] [Full Text] [Related] Page: [Next] [New Search]